Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| NCT ID | NCT04047290 |
| Title | A Study of AK112, a PD-1/VEGF Bispecific Antibody, for Advanced Solid Tumors |
| Recruitment | Completed |
| Gender | both |
| Phase | Phase I |
| Variant Requirements | No |
| Sponsors | Akesobio Australia Pty Ltd |
| Indications | |
| Therapies | |
| Age Groups: | senior | adult |
| Covered Countries | AUS |
| Facility | Status | City | State | Zip | Country | Details |
|---|---|---|---|---|---|---|
| Border Medical Oncology | Albury | New South Wales | Australia | Details | ||
| Scientia Clinical Research Ltd | Randwick | New South Wales | Australia | Details | ||
| Blacktown Hospital | Sydney | New South Wales | Australia | Details | ||
| ICON Cancer Foundation | South Brisbane | Queensland | Australia | Details | ||
| Adelaide Cancer Centre | Kurralta Park | South Australia | Australia | Details | ||
| Monash Health | Clayton | Victoria | Australia | Details | ||
| Peter MacCallum Cancer Centre | Melbourne | Victoria | Australia | Details |